干细胞疗法:多发性硬化症治疗的新时代。

Stem cell therapies: a new era in the treatment of multiple sclerosis.

作者信息

Wu Lei, Lu Jing, Lan Tianye, Zhang Dongmei, Xu Hanying, Kang Zezheng, Peng Fang, Wang Jian

机构信息

Changchun University of Chinese Medicine, Changchun, China.

The Affiliated Hospital to Changchun University of Traditional Chinese Medicine, Changchun, China.

出版信息

Front Neurol. 2024 May 9;15:1389697. doi: 10.3389/fneur.2024.1389697. eCollection 2024.

Abstract

Multiple Sclerosis (MS) is an immune-mediated condition that persistently harms the central nervous system. While existing treatments can slow its course, a cure remains elusive. Stem cell therapy has gained attention as a promising approach, offering new perspectives with its regenerative and immunomodulatory properties. This article reviews the application of stem cells in MS, encompassing various stem cell types, therapeutic potential mechanisms, preclinical explorations, clinical research advancements, safety profiles of clinical applications, as well as limitations and challenges, aiming to provide new insights into the treatment research for MS.

摘要

多发性硬化症(MS)是一种免疫介导的疾病,会持续损害中枢神经系统。虽然现有治疗方法可以减缓其病程,但治愈方法仍然难以捉摸。干细胞疗法作为一种有前景的方法受到了关注,因其具有再生和免疫调节特性而提供了新的视角。本文综述了干细胞在MS中的应用,包括各种干细胞类型、治疗潜在机制、临床前探索、临床研究进展、临床应用的安全性概况以及局限性和挑战,旨在为MS的治疗研究提供新的见解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索